The rising interest in GLP-1 agonists for diabetes has sparked a debate about delivery routes : skin-applied devices versus tablets . Usually , GLP-1 drugs were only available in tablet form, but the https://jaysonqlje346436.dbblog.net/14260898/glp-1-skin-applications-vs-tablets-which-best-for-the-patient